NextCure, Inc. Files 2024 Annual Report
Ticker: NXTC · Form: 10-K · Filed: Mar 6, 2025 · CIK: 1661059
| Field | Detail |
|---|---|
| Company | Nextcure, Inc. (NXTC) |
| Form Type | 10-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, financials, pharmaceuticals
TL;DR
NextCure's 2024 10-K shows $279.6M assets vs $27.8M liabilities. Solid balance sheet.
AI Summary
NextCure, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, incorporated in Delaware and headquartered in Beltsville, MD, operates in the pharmaceutical preparations sector. Key financial figures for the year include total assets of $279.6 million and total liabilities of $27.8 million, resulting in a net worth of approximately $251.8 million.
Why It Matters
This filing provides a comprehensive overview of NextCure's financial health and operational status for the past fiscal year, which is crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard annual report with no immediate red flags or significant negative events indicated.
Key Numbers
- $279.6M — Total Assets (As of December 31, 2024)
- $27.8M — Total Liabilities (As of December 31, 2024)
- $251.8M — Total Equity (Calculated as Total Assets - Total Liabilities for FY 2024)
Key Players & Entities
- NextCure, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 20250306 (date) — Filing date
- Beltsville, MD (location) — Company headquarters
- $279.6 million (dollar_amount) — Total assets for FY 2024
- $27.8 million (dollar_amount) — Total liabilities for FY 2024
FAQ
What were NextCure's total revenues for the fiscal year ending December 31, 2024?
The provided text does not explicitly state the total revenues for the fiscal year ending December 31, 2024. It focuses on balance sheet items.
What is the company's primary business activity?
NextCure, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was NextCure, Inc. incorporated and where is it headquartered?
NextCure, Inc. was incorporated in Delaware and is headquartered at 9000 Virginia Manor Road, Suite 200, Beltsville, MD 20705.
What was the filing date for this 10-K report?
This 10-K report was filed on March 6, 2025.
What were the accrued liabilities as of December 31, 2024?
The filing mentions 'AccruedAndOtherLiabilitiesCurrent' with values of $28,006,684 for 2024 and $27,903,027 for 2023.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 6, 2025 regarding NextCure, Inc. (NXTC).